30/03/2008 |
Whilst motor neurone disease remains a devastating illness, and no breakthrough has been made in terms of a cure, patients can be offered various interventions to enable longer survival with maintenance of independence and a good quality of life, a clinical review in the BMJ concludes.Source: McDermott, C. BMJ; 336:658:662.
30/01/2007 | Sanofi-aventis has welcomed the Federal Government's decision to lift the age restriction applied to riluzole (Rilutek®) on the Pharmaceutical Benefits Scheme.
08/08/2005 | A review examining evidence for the involvement of apoptosisis in ALS motor neurone degeneration also describes potential therapeutic agents that could modulate the pathway and slow disease progression.Source: Sathasivam, S. et al. Lancet Neurol 2005; 4: 500-509.
28/07/2005 | Japanese neurologists reporting their success with cyclosporin for intractable CIDP suggest a treatment protocol that includes the immunosuppressive agent for maintenance therapy in intractable cases.Source: Odaka, M. et al. JNNP 2005; 76:1115-1120.
12/04/2005 | An editorial in the MJA describes the glutamate antagonist riluzole as 'a glimmer of hope in the treatment of motor neurone disease'. Source: Kiernan, M. MJA, 2005, 182:319-320.
22/03/2005 | Australian authors reviewing current methods for assessing motor neuron disease say there are still many challenges in diagnosis and monitoring of disease progression.Source: Winhammar, J. et al. Lancet Neurol 2005, 4:229-238.
18/02/2005 | Bilateral deep brain stimulation of the globus pallidus improves movement and functional disability in adult patients with generalised dystonia.Source: Vidailhet, M. et al. NEJM 2005, 352:459-467.
17/01/2005 | Despite recent studies suggesting an increased risk of ALS in Gulf War veterans, the risk appears to extend to other military conflicts, according to a recent report. Source: Weisskopf, M. et al. Neurology 2005, 64: 32-37
09/11/2004 | A defined combination of dextromethorphan hydrobromide and quinidine sulphate is an effective treatment of pseudobulbar affect in patients with amyotrophic lateral sclerosis, a report in Neurology shows.
19/10/2004 | Authors of a study published in Neurology report that intravenous immunoglobulin (IVIg) therapy is an effective long-term therapy for multifocal motor neuropathy with conduction blocks.